News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
71,247 Results
Type
Article (1429)
Company Profile (17)
Press Release (69801)
Section
Business (31949)
Career Advice (48)
Deals (4699)
Drug Delivery (1)
Drug Development (7465)
Employer Resources (5)
FDA (1431)
Job Trends (1592)
News (43421)
Policy (2301)
Tag
Academia (132)
Accelerated approval (1)
Allergies (21)
Alliances (2661)
ALS (10)
Alzheimer's disease (223)
Antibody-drug conjugate (ADC) (20)
Approvals (1512)
Artificial intelligence (27)
Autoimmune disease (7)
Automation (5)
Bankruptcy (31)
Best Places to Work (1547)
BIOSECURE Act (1)
Biosimilars (11)
Biotechnology (8)
Bladder cancer (35)
Brain cancer (3)
Breast cancer (72)
Cancer (482)
Cardiovascular disease (36)
Career advice (44)
Career pathing (1)
CAR-T (14)
CDC (2)
Cell therapy (55)
Cervical cancer (4)
Clinical research (6961)
Collaboration (70)
Compensation (43)
Complete response letters (3)
COVID-19 (139)
CRISPR (8)
C-suite (22)
Cystic fibrosis (12)
Data (762)
Depression (8)
Diabetes (56)
Diagnostics (648)
Digital health (4)
Diversity, equity & inclusion (3)
Drug discovery (8)
Drug pricing (4)
Duchenne muscular dystrophy (10)
Earnings (29025)
Editorial (1)
Employer resources (5)
Events (9389)
Executive appointments (28)
FDA (1951)
Fibrodysplasia Ossificans Progressiva (2)
Frontotemporal dementia (4)
Funding (61)
Gene editing (14)
Generative AI (1)
Gene therapy (44)
GLP-1 (81)
Government (243)
Guidances (232)
Healthcare (2027)
HIV (2)
Huntington's disease (3)
IgA nephropathy (10)
Immunology and inflammation (22)
Immuno-oncology (1)
Indications (7)
Infectious disease (166)
Inflammatory bowel disease (8)
Influenza (8)
Intellectual property (19)
Interviews (4)
IPO (3533)
IRA (1)
Job creations (133)
Job search strategy (41)
Labor market (3)
Layoffs (15)
Leadership (2)
Legal (392)
Liver cancer (5)
Lung cancer (67)
Lymphoma (69)
Machine learning (2)
Manufacturing (35)
MASH (22)
Medical device (2125)
Medtech (2129)
Mergers & acquisitions (1235)
Metabolic disorders (120)
Multiple sclerosis (36)
NASH (3)
Neurodegenerative disease (20)
Neuropsychiatric disorders (10)
Neuroscience (363)
NextGen: Class of 2025 (553)
Non-profit (258)
Obesity (42)
Opinion (3)
Ovarian cancer (13)
Pain (11)
Pancreatic cancer (16)
Parkinson's disease (42)
Patents (26)
Patient recruitment (21)
Peanut (15)
People (2479)
Pharmaceutical (5)
Pharmacy benefit managers (2)
Phase I (1613)
Phase II (2793)
Phase III (3000)
Pipeline (1200)
Policy (4)
Postmarket research (254)
Preclinical (515)
Press Release (4)
Prostate cancer (22)
Radiopharmaceuticals (25)
Rare diseases (55)
Real estate (284)
Recruiting (3)
Regulatory (2016)
Reports (9)
Research institute (123)
Resumes & cover letters (2)
Rett syndrome (5)
RSV (16)
Schizophrenia (19)
Series A (11)
Series B (5)
Service/supplier (1)
Sickle cell disease (8)
Special edition (2)
Spinal muscular atrophy (8)
Sponsored (3)
Startups (117)
Stomach cancer (1)
Supply chain (8)
The Weekly (1)
Vaccines (68)
Venture capital (2)
Weight loss (27)
Women's health (5)
Date
Last 7 days (41)
Last 30 days (698)
Last 365 days (4605)
2025 (4396)
2024 (4716)
2023 (5356)
2022 (6384)
2021 (7213)
2020 (6571)
2019 (5329)
2018 (3995)
2017 (3480)
2016 (2482)
2015 (3651)
2014 (2599)
2013 (1425)
2012 (1526)
2011 (1758)
2010 (1504)
Location
Africa (44)
Alabama (6)
Arizona (17)
Asia (3212)
Australia (389)
California (1396)
Canada (393)
China (77)
Colorado (71)
Connecticut (69)
Delaware (42)
Europe (8762)
Florida (199)
Georgia (83)
Hawaii (1)
Idaho (9)
Illinois (167)
India (2)
Indiana (84)
Iowa (5)
Japan (34)
Kansas (9)
Kentucky (4)
Louisiana (8)
Maine (42)
Maryland (216)
Massachusetts (860)
Michigan (110)
Minnesota (92)
Mississippi (1)
Missouri (14)
Montana (3)
Nevada (16)
New Hampshire (11)
New Jersey (542)
New York (543)
North Carolina (252)
North Dakota (2)
Northern California (708)
Ohio (42)
Oklahoma (1)
Oregon (3)
Pennsylvania (268)
Puerto Rico (1)
Rhode Island (2)
South America (84)
South Carolina (3)
Southern California (565)
Tennessee (15)
Texas (239)
United States (5513)
Utah (45)
Virginia (15)
Washington D.C. (7)
Washington State (130)
West Virginia (1)
Wisconsin (12)
71,247 Results for "84".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Cancer Diagnostics Market Size to Hit USD 359.84 Billion by 2034
November 24, 2025
·
1 min read
Press Releases
Pharmaceutical Excipients Outlook 2025–2032: Strong CAGR of 8.4% with USD 19.29 Billion Valuation
October 3, 2025
·
1 min read
Press Releases
Stryker declares an $0.84 per share quarterly dividend
August 8, 2025
·
1 min read
Press Releases
Viral Vector Development Market to Reach USD 5.00 Billion at 18.84% CAGR by 2034
August 19, 2025
·
1 min read
Press Releases
Gyala Therapeutics unveils first-in-class CAR-T therapy targeting CD84 showing strong preclinical efficacy in hard-to-treat leukemias
September 15, 2025
·
4 min read
Press Releases
Angelini Ventures Co-leads CHF 79 Million (€84 Million) Series B Financing of NUCLIDIUM to Advance Clinical Development of its Copper-based Radiopharmaceutical Platform
July 10, 2025
·
5 min read
BioMidwest
Veru to Present at the American Diabetes Association’s 84th Scientific Sessions
Veru Inc. announced that the Company will present two presentations at the American Diabetes Association’s 84th Scientific Sessions, taking place June 21-24, 2024, in Orlando, Florida.
June 10, 2024
·
10 min read
Press Releases
Vizient Forecasts a 3.84% Rise in Pharmacy Spending
January 28, 2025
·
5 min read
Press Releases
Elutia Announces Strong First Quarter 2025 Financial Results Driven by 84% Sequential Growth in EluPro™ Sales
May 9, 2025
·
13 min read
FDA
SpliSense Receives FDA Fast Track Designation for SPL84 for the Treatment of Cystic Fibrosis
SpliSense today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to SPL84 for CF.
May 29, 2024
·
3 min read
1 of 7,125
Next
